AMERIPRISE FINANCIAL INC - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 240 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$63,573,000
+41.3%
367,887
-6.0%
0.04%
+38.5%
Q4 2014$44,994,000
-72.5%
391,459
-62.6%
0.03%
-73.5%
Q3 2014$163,437,000
-24.1%
1,046,068
-40.1%
0.10%
-22.8%
Q2 2014$215,271,000
+22.6%
1,745,238
+3.0%
0.13%
+21.0%
Q1 2014$175,539,000
-5.1%
1,694,261
-17.6%
0.10%
-6.2%
Q4 2013$185,010,000
+32.6%
2,057,050
-1.4%
0.11%
+21.7%
Q3 2013$139,507,000
+13.5%
2,085,937
+12.3%
0.09%
+8.2%
Q2 2013$122,900,0001,857,8790.08%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
Consonance Capital Management LP 467,943$30,954,00011.01%
TANG CAPITAL MANAGEMENT LLC 300,000$19,845,0007.82%
OAK RIDGE INVESTMENTS LLC 1,382,895$91,478,0002.87%
SECTOR GAMMA AS 147,001$9,724,0002.84%
Credo Capital Management, LLC 38,869$2,571,0001.98%
Cardinal Capital Management 48,226$3,190,0001.89%
ZEVENBERGEN CAPITAL INVESTMENTS LLC 626,800$41,463,0001.68%
HERNDON CAPITAL MANAGEMENT LLC 1,284,472$84,967,823,0001.27%
CATAPULT CAPITAL MANAGEMENT LLC 45,000$2,977,0001.24%
Pier Capital, LLC 108,556$7,181,0001.10%
View complete list of SALIX PHARMACEUTICALS INC shareholders